MAOA and prostate carcinoma: A recent study discovered that MAOA (monoamine oxidase A) in stromal cells promotes their myCAF conversion, and MAOA inhibition prevented intracellular ROS accumulation, boosting WNT5A secretion to enhance the Ca2+-NFATC1 pathway in CD8 + T-cells, thus suppressing prostate cancer growth.